Rua Life Sciences Share Discussion Threads

[bones] 07/2/2024 15:49

Harrogate, in a word, yes!

[harrogate] 07/2/2024 13:47

Don't you find that often the words are intriguing and promising - majors visiting us etc etc - but the actions less so?

[bones] 07/2/2024 13:39

I also thought the comment in the RNS announcing Stretton's departure was intriguing, if cryptic, but opens up many possibilities of outside interest or investment:

"RUA is pursuing a number of opportunities to develop the business further and these will play a part in the future shape of the senior leadership team."

For a development to play a part in the formation of the senior leadership team suggests something of size. Whether that comes from internal sources or outside interest (more likely) remains to be seen.

[bones] 07/2/2024 12:56

Thread header now updated and cleaned up to reflect current information and shareholder lists.

[bones] 07/2/2024 00:03

Last summer at the AGM, the RUA board said they would not dilute the other businesses by raising the money (£6M approx) needed for the Vascular graft clinical trials and instead would seek outside finance, however that might manifest itself. They confirmed that in the interims in December (but did of course raise and dilute to keep heart valve financed).

In the webinar that followed, Bill was asked in Q&A about how that was going and what action was being taken to find a buyer or partner. In near enough his words, he said:

“I’m not going to speculate on company names or people we may have been speaking to. There are potential financial backers and a potential industry backer but I’m not going to speculate on what we are doing or what the detailed processes are but we are working on it.”

My own guess based on that wording of “financial backers and an industry backer” is it could be Corcym and/or their financial backers, Gyrus Capital. That would seem to make logical sense given that Corcym are already signed up for the ultimate sales distributor role worldwide. Why would that group of backers not want to throw a relatively small sum (for them) at this and help get the vascular graft through trials and the bulk of sales into their pockets? At the moment, they have a 50/50 deal on sales but that could be skewed further to Corcym in exchange for financing the trial.

All speculation on my part but in my opinion should be the bookies favourite, if the vascular graft is ever to get off the ground!

[hedgehog11] 30/1/2024 16:23

Thanks Harrogate - to confirm "Grant Thornton UK LLP ("Grant Thornton") has resigned as the Group's auditor." They resign because RUA chose to replace them, is that the normal process?

[harrogate] 30/1/2024 12:14

They haven't quit they have lost the audit after a competitive tender as it says clearly. It happens and hopefully we have saved a few bob

[hedgehog11] 30/1/2024 12:00

All quiet on the comments board after todays announcement. The auditors haven't quit because the fee has shrunk, because it won't have. I doubt Caroline's exit was enough for them to quit, despite the announcement coming the day after. So why have they? Do they feel like RUA are hiding something from them, like the terms of a grant or details of the recent fund raise. Just when you think the bottom has been reached this throws up more doubt.

[hedgehog11] 29/1/2024 09:07

The only surprise is what took so long to announce it.

[t0pgrader] 29/1/2024 08:04

Seems like good news to me. Never felt she added much.

[parsons4] 29/1/2024 08:00

I don't think that anybody here is surprised by this morning's RNS !! CS has not been included in the goings on in the last 6 months or so. "Rua is persuing a number of opportunities to develop the business further and these will play a part in the future shape of the senior leadership team". To me this indicates that the new heart valve business is starting to come to fruition and the manufacturing capability will need to be expanded. Lot's of near term news can be expected IMHO of course.

[parsons4] 29/1/2024 08:00

I don't think that anybody here is surprised by this morning's RNS !! CS has not been included in the goings on in the last 6 months or so. "Rua is persuing a number of opportunities to develop the business further and these will play a part in the future shape of the senior leadership team". To me this indicates that the new heart valve business is starting to come to fruition and the manufacturing capability will need to be expanded. Lot's of near term news can be expected IMHO of course.

[babbler] 29/1/2024 07:41

She didn't make any comment in the rns which usually means pushed.

[langland] 29/1/2024 07:29

Understandable that she would be leaving after she did not take part in the recent fund raising. With the departure of the director for regulatory affairs a few months ago and this departure this takes about 330k costs out of the business. The above comment assumes that she is leaving voluntarily.

[amt] 29/1/2024 07:13

Well if She is leaving it doesn't sound like the prospects are good

[trotterstrading] 26/1/2024 13:41

Building up steam for another attack on that resistance level

[trotterstrading] 19/1/2024 16:00

Just working through the book, when they ready the MM's will let it go.. won't be long now

[7767] 19/1/2024 15:54

Weird pricing when bring sold this morn priced moved up blue. When being bought this after price dropped red. Any one any thoughts.

[trotterstrading] 19/1/2024 14:34

Still a few placee's to burn off before we break free of the shackles.. it will come